Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Conditions

Breast Neoplasms 4358Neoplasms 3060Prostatic Neoplasms 1904Colorectal Neoplasms 1739Lung Neoplasms 1557Carcinoma, Non-Small-Cell Lung 1270Pancreatic Neoplasms 981Leukemia, Myeloid, Acute 952Multiple Myeloma 951Lymphoma 912Head and Neck Neoplasms 894Leukemia 852Precursor Cell Lymphoblastic Leukemia-Lymphoma 833Neoplasm Metastasis 794Colonic Neoplasms 786Carcinoma, Hepatocellular 762Ovarian Neoplasms 758Melanoma 752Stomach Neoplasms 743Rectal Neoplasms 701Brain Neoplasms 699Lymphoma, Non-Hodgkin 663Leukemia, Lymphocytic, Chronic, B-Cell 618Uterine Cervical Neoplasms 608Lymphoma, Follicular 559Glioblastoma 542Recurrence 541Hodgkin Disease 532Esophageal Neoplasms 527Myelodysplastic Syndromes 508

Interventions

High-Energy Shock Waves 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × OTHER × Risk Malignant Index × Clear all
NCT03404687 2018-01-19

Risk of Malignancy Index and Assiut Scoring Model for Adnexal Malignancy

Assiut University

Completed
250 enrolled

Risk Malignant Index

Data powered by HemOnc (CC BY 4.0) Colophon âš¡